Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07046897

Analysis of the Gut Microbiota Composition After Consumption of Probiotic Bacteria

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Lund University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this intervention study is to evaluate the beneficial effect of the probiotic bacterium Bacillus coagulans in healthy volunteers. The main question it aims to answer is if the probiotic strains are modifying the microbiota composition in a beneficial way, evaluated in faecal- and saliva samples. Primary hypothesis: The probiotic bacteria will modify the microbiota composition in faecal- and saliva samples. Participants will consume the freeze-dried probiotic bacteria for 14 days. Before and after consumption, the participants will collect samples.

Detailed description

Samples will be frozen immediately after collection and will be kept frozen until analysis at the Department of Process and Life Science Engineering, Faculty of Engineering, Lund University. For diversity measures, species identification and relative abundance of bacterial taxa, samples will be analysed by Illuminas MiSeq with the MiSeq reagent kit v3. Data will be analysed with bioinformatic pipeline QIIME2TM.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTConsumption of probiotics strain 5Consumption of probiotic capsules containing the probiotic bacteria Bacillus coagulans strain 5.
DIETARY_SUPPLEMENTConsumption of probiotics strain 6Consumption of probiotic capsules containing the probiotic bacteria Bacillus coagulans strain 6.

Timeline

Start date
2024-11-12
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2025-07-02
Last updated
2025-07-02

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07046897. Inclusion in this directory is not an endorsement.